FACT II Acquisition Corp
NASDAQ:FACTShell Companies
+$0.01 today
- Market cap
- $263.16M
- Beta
- 0.04
- P/E (TTM)
- 42.8
- EPS (TTM)
- $0.25
Volume 0.74M
Average 0.10M
FACT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
FACT II Acquisition CorpNASDAQ: FACT
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How FACT compares with its peers on the latest reported figures
- FACT's LTM Mar 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
MACIMelar Acquisition Corp. I | LTM Mar 2026 | $0 | — | — | — |
LEGTLegato Merger Corp. III | LTM Feb 2026 | $0 | — | — | — |
COPLCopley Acquisition Corp | LTM Mar 2026 | $0 | — | — | — |
| FY2022 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding FACT) | $0 | — | — | — | |
Competitors are the stored peer set for FACT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 87.62M | 108.74M | 0 |
| Cost of Revenue | 3.78M | 4.41M | 69.83M | 69.24M | 0 |
| Gross Profit | (3.78M) | (4.41M) | 17.79M | 39.5M | 0 |
| Gross Margin | — | — | 20.3% | 36.3% | — |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 39.02M | 83.42M | 2.23M |
| Operating Expenses | 3.78M | 4.41M | 39.02M | 83.42M | 2.23M |
| Depreciation & Amortization | 0 | 0 | 57.89M | 2.16M | 0 |
| EBITDA | (3.78M) | (4.41M) | (52.36M) | (68.51M) | (2.23M) |
| EBITDA Margin | — | — | -59.8% | -63.0% | — |
| Operating Income | (3.78M) | (4.41M) | (52.36M) | (68.51M) | (2.23M) |
| Operating Margin | — | — | -59.8% | -63.0% | — |
| Interest Income | 105.68K | 4.82M | 36K | 19K | 7.22M |
| Interest Expense | 0 | 0 | (14.03M) | (16.22M) | 0 |
| Other Income / Expenses | 8.91M | 10.39M | (43.86M) | 14.07M | 7.24M |
| Income Before Tax | 5.13M | 5.98M | (96.22M) | (54.44M) | 5.02M |
| Pre-Tax Margin | — | — | -109.8% | -50.1% | — |
| Income Tax Expense | 0 | 0 | 20K | 2.01M | 0 |
| Net Income | 5.13M | 5.98M | (269.56M) | (56.45M) | 5.02M |
| Net Margin | — | — | -307.7% | -51.9% | — |
| EPS (Basic) | 0.20 | 0.14 | (10.90) | (2.26) | 0.27 |
| EPS (Diluted) | 0.12 | 0.14 | (10.90) | (2.26) | 0.27 |
| Weighted Avg Shares | 25.31M | 34.5M | 24.72M | 24.96M | 18.49M |
| Weighted Avg Shares (Diluted) | 42.56M | 34.5M | 24.72M | 24.96M | 18.49M |
FACT II Acquisition Corp
NASDAQ:FACT
Intrinsic Alpha fair value
Locked
Current Price
$10.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.